Category: Press Releases

Dr. Theodore Liston to Lead Pharmacokinetics and Pharmacodynamics at Astrocyte Pharmaceuticals

Cambridge, Mass., May 1, 2015 – Astrocyte Pharmaceuticals Inc., a privately held pharmaceutical company, announced today that Theodore E. Liston, Ph.D. has joined the company as Vice President of Pharmacokinetics...

Astrocyte’s Dr. James Lechleiter to Present at 2015 TBI Conference

The 5th Annual Traumatic Brain Injury (TBI) Conference is being held on April 15 and 16, 2015 in Washington DC. The conference will feature the latest research findings from many leading TBI researchers...

Former Satori CEO & Pfizer Executive Jeffrey Ives Joins Board of Astrocyte Pharmaceuticals

Cambridge, Mass., December 1, 2014 – Astrocyte Pharmaceuticals Inc., a privately held pharmaceutical company, today announced that Jeffrey L. Ives, Ph.D. has joined the company’s Board of Directors....

Developing innovative neuroprotection therapies for Traumatic Brain Injuries (TBI), concussions, stroke, and neurodegenerative disorders